Australia markets close in 3 hours 10 minutes
  • ALL ORDS

    7,719.40
    +2.30 (+0.03%)
     
  • ASX 200

    7,397.30
    +3.40 (+0.05%)
     
  • AUD/USD

    0.7201
    -0.0010 (-0.13%)
     
  • OIL

    84.49
    +0.67 (+0.80%)
     
  • GOLD

    1,814.80
    -1.70 (-0.09%)
     
  • BTC-AUD

    59,635.16
    -548.00 (-0.91%)
     
  • CMC Crypto 200

    1,034.13
    +8.40 (+0.82%)
     
  • AUD/EUR

    0.6311
    -0.0001 (-0.02%)
     
  • AUD/NZD

    1.0602
    +0.0010 (+0.10%)
     
  • NZX 50

    12,754.24
    -35.92 (-0.28%)
     
  • NASDAQ

    15,611.59
    +115.99 (+0.75%)
     
  • FTSE

    7,542.95
    -20.90 (-0.28%)
     
  • Dow Jones

    35,911.81
    -201.79 (-0.56%)
     
  • DAX

    15,883.24
    -148.36 (-0.93%)
     
  • Hang Seng

    24,277.20
    -106.12 (-0.44%)
     
  • NIKKEI 225

    28,358.07
    +233.79 (+0.83%)
     

US panel weighs whether to OK Merck COVID-19 pill

U.S. health advisers are reviewing Merck's closely watched COVID-19 pill, which could become the first easy-to-use drug for American patients. The FDA asked its outside experts Tuesday whether the agency should authorize the pill. (Nov. 30)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting